Finerenone added to SGLT2 inhibitor and GLP-1 receptor agonist therapy

Research studies on Finerenone added to SGLT2 inhibitor and GLP-1 receptor agonist therapy - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.